Niu XD - Search Results

1

CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue.

Cook DN, Prosser DM, Forster R, Zhang J, Kuklin NA, Abbondanzo SJ, Niu XD, Chen SC, Manfra DJ, Wiekowski MT, Sullivan LM, Smith SR, Greenberg HB, Narula SK, Lipp M, Lira SA. Cook DN, et al. Among authors: niu xd. Immunity. 2000 May;12(5):495-503. doi: 10.1016/s1074-7613(00)80201-0. Immunity. 2000. PMID: 10843382 Free article.

2

Expression of human inducible nitric oxide synthase in Escherichia coli.

Fossetta JD, Niu XD, Lunn CA, Zavodny PJ, Narula SK, Lundell D. Fossetta JD, et al. Among authors: niu xd. FEBS Lett. 1996 Jan 29;379(2):135-8. doi: 10.1016/0014-5793(95)01496-9. FEBS Lett. 1996. PMID: 8635578 Free article.

3

Inhibition of fucosyltransferase VII by gallic acid and its derivatives.

Niu X, Fan X, Sun J, Ting P, Narula S, Lundell D. Niu X, et al. Arch Biochem Biophys. 2004 May 1;425(1):51-7. doi: 10.1016/j.abb.2004.02.039. Arch Biochem Biophys. 2004. PMID: 15081893

4

Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation.

Fischmann TO, Hruza A, Niu XD, Fossetta JD, Lunn CA, Dolphin E, Prongay AJ, Reichert P, Lundell DJ, Narula SK, Weber PC. Fischmann TO, et al. Among authors: niu xd. Nat Struct Biol. 1999 Mar;6(3):233-42. doi: 10.1038/6675. Nat Struct Biol. 1999. PMID: 10074942

5

Development of a prodrug of hydantoin based TACE inhibitor.

Tong L, Kim SH, Chen L, Kosinski A, Shankar BB, Girijavallabhan V, Yang DY, Yu W, Zhou G, Shih NY, Chen S, Hu M, Lundell D, Niu X, Umland S, Kozlowski JA. Tong L, et al. Bioorg Med Chem Lett. 2017 Aug 15;27(16):3704-3708. doi: 10.1016/j.bmcl.2017.07.007. Epub 2017 Jul 3. Bioorg Med Chem Lett. 2017. PMID: 28711352

6

Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors: Part I--discovery of two binding modes.

Zhu Z, Mazzola R, Sinning L, McKittrick B, Niu X, Lundell D, Sun J, Orth P, Guo Z, Madison V, Ingram R, Beyer BM. Zhu Z, et al. J Med Chem. 2008 Feb 28;51(4):725-36. doi: 10.1021/jm070376o. Epub 2008 Feb 5. J Med Chem. 2008. PMID: 18247549

7

Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors. Part II: optimization of the S3' pocket.

Mazzola RD Jr, Zhu Z, Sinning L, McKittrick B, Lavey B, Spitler J, Kozlowski J, Neng-Yang S, Zhou G, Guo Z, Orth P, Madison V, Sun J, Lundell D, Niu X. Mazzola RD Jr, et al. Bioorg Med Chem Lett. 2008 Nov 1;18(21):5809-14. doi: 10.1016/j.bmcl.2008.09.045. Epub 2008 Sep 13. Bioorg Med Chem Lett. 2008. PMID: 18835710

8

Discovery of novel spirocyclopropyl hydroxamate and carboxylate compounds as TACE inhibitors.

Guo Z, Orth P, Wong SC, Lavey BJ, Shih NY, Niu X, Lundell DJ, Madison V, Kozlowski JA. Guo Z, et al. Bioorg Med Chem Lett. 2009 Jan 1;19(1):54-7. doi: 10.1016/j.bmcl.2008.11.034. Epub 2008 Nov 14. Bioorg Med Chem Lett. 2009. PMID: 19054672

9

IK682, a tight binding inhibitor of TACE.

Niu X, Umland S, Ingram R, Beyer BM, Liu YH, Sun J, Lundell D, Orth P. Niu X, et al. Arch Biochem Biophys. 2006 Jul 1;451(1):43-50. doi: 10.1016/j.abb.2006.03.034. Epub 2006 May 5. Arch Biochem Biophys. 2006. PMID: 16762314

10

Fused bi-heteroaryl substituted hydantoin compounds as TACE inhibitors.

Tong L, Kim SH, Rosner K, Yu W, Shankar BB, Chen L, Li D, Dai C, Girijavallabhan V, Popovici-Muller J, Yang L, Zhou G, Kosinski A, Siddiqui MA, Shih NY, Guo Z, Orth P, Chen S, Lundell D, Niu X, Umland S, Kozlowski JA. Tong L, et al. Bioorg Med Chem Lett. 2017 Jul 15;27(14):3037-3042. doi: 10.1016/j.bmcl.2017.05.062. Epub 2017 May 22. Bioorg Med Chem Lett. 2017. PMID: 28558971

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page